Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2024
Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement as well as by infections and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.
In this multidisciplinary symposium, clinical experts from Memorial Sloan Kettering (MSK) and around the world, will present an up-to-date overview on cutting edge cancer therapies and best practice strategies in the evaluation and management of lung disease. The purpose of this conference is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer.
The symposium offers participants the choice of attending either in person or virtually and is intended for healthcare professionals in pulmonology, hematology and oncology, and other disciplines involved in the care of cancer patients or who have a special interest in this area.
- Explain the role of the pulmonologist in diagnosis and management of lung cancer
- Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
- Implement strategies for diagnosis and management of infectious and non-infectious pulmonary complications of stem cell transplant
- Discuss multidisciplinary approach in complex patients.
- Explain the diagnosis and clinical significance of pre-existing interstitial lung abnormalities and interstitial lung disease in cancer management
Price : $ 70
